SIGA Technologies, Inc. (SIGA)


-0.06 (-0.46%)
Symbol SIGA
Price $13.04
Beta 0.455
Volume Avg. 9.27M
Market Cap 944.183M
Shares () -
52 Week Range 5.66-14.8
1y Target Est -
DCF Unlevered SIGA DCF ->
DCF Levered SIGA LDCF ->
ROE 49.46% Strong Buy
ROA 37.88% Strong Buy
Operating Margin -
Debt / Equity 10.02% Neutral
P/E 13.99 Strong Buy
P/B 5.68 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest SIGA news

Dr. Phillip Gomez
Drug Manufacturers—Specialty & Generic
NASDAQ Global Market

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.